DR. GLEN H. MURATA, M.D.
Osteopathic Medicine at San Pedro Dr, Albuquerque, NM
License number
New Mexico 87-122
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
1501 San Pedro Dr SE, Albuquerque, NM 87108
Phone
(505) 256-2727
(505) 256-2888 (Fax)
(505) 823-9290
(505) 256-2888 (Fax)
(505) 823-9290
Professional information
Dr. Glen H Murata, Albuquerque NM - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine
Address:
111GIM
1501 San Pedro Dr SE, Albuquerque 87108
(505) 256-2727 (Phone), (505) 256-2888 (Fax)
1501 San Pedro Dr SE, Albuquerque 87108
(505) 256-2727 (Phone), (505) 256-2888 (Fax)
Certifications:
Critical Care Medicine, 1989, Internal Medicine, 1976
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Johns Hopkins University / School of Medicine
Graduated: 1973
Cedars Sinai Medical Center
Johns Hopkins University / School of Medicine
Graduated: 1973
Cedars Sinai Medical Center
Glen Hiroshi Murata, Albuquerque NM
Specialties:
Internist
Address:
1501 San Pedro Dr Se, Albuquerque, NM 87108
Education:
Johns Hopkins University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Glen H Murata, Albuquerque NM
Specialties:
Internal Medicine
Work:
New Mexico Veterans Affairs Healthcare Center
1501 San Pedro Dr SE, Albuquerque, NM 87108
1501 San Pedro Dr SE, Albuquerque, NM 87108
Education:
Johns Hopkins University (1973)
System And Methods For Estimating Hba1C, Treatment Response, And Hypoglycemia Risk Using Self-Monitoring Of Blood Glucose Data
US Patent:
2012025, Oct 4, 2012
Filed:
Oct 25, 2010
Appl. No.:
13/505103
Inventors:
Glen H. Murata - Albuquerque NM, US
Assignee:
STC.UNM - Albuquerque NM
International Classification:
G06Q 50/22
US Classification:
705 2
Abstract:
A system and method for estimating HbA1diabetic patient treatment response and hypoglycemia risk using data obtained from patient self-monitoring of blood glucose. The system includes a computer having a processor, data storage, display, and data input ports. The data storage stores an insulin manager module that has instructions performed by the processor when self-monitoring of blood glucose (SMBD) data is provided to the computer via one of the data input ports. The processor uses the SMBD data to generate reports displaying estimated HbAIc and other factors effecting blood glucose levels in a diabetic patient and prescribes insulin treatment plans.
Methods For Predicting The Response To Statins
US Patent:
2011024, Oct 6, 2011
Filed:
Dec 21, 2010
Appl. No.:
12/928894
Inventors:
Glen H. Murata - Albuquerque NM, US
International Classification:
A61K 31/505, A61K 31/40, A61K 31/404, A61K 31/366, A61K 31/22, A61K 31/47, A61P 9/10, G06G 7/60
US Classification:
514275, 514423, 514419, 514460, 514510, 514311, 703 11
Abstract:
The invention provides methods for optimizing therapeutic efficacy for treating hypercholesterolemia in a subject having a cardiovascular disease (CVD), comprising (a) determining subject characteristics that affect the likelihood of reaching a goal level of low density lipoprotein (LDL); and (b) obtaining success probabilities of a variety of statin treatments for reaching said goal level of LDL using said subject characteristics and a multivariate model; and (c) administrating the optimal statin treatment with the highest success probability of step (b) to said subject thereby optimizing therapeutic efficacy for treating hypercholesterolemia in said subject.